Chiltern Launches “Chiltern Safe”, a Comprehensive Global Trial Master File Management Solution

November 15, 2010
Research and Development

“Chiltern SAFE is revolutionizing records management for clinical trials”, stated Sarah Hitching, Chiltern Director, Records Management. “This complete electronic Trial …

quintiles_john_procter

Pfizer’s John Proctor moves to Quintiles

November 15, 2010
Sales and Marketing John Proctor, Pfizer, Quintiles, UK, appointment, sales and marketing

Quintiles has appointed the former head of Pfizer Health Solutions to lead its own Health Management Solutions (HMS) business. As …

Katina

When should pharma leaders trust their gut instinct?

November 15, 2010
Business Services, Sales and Marketing decision making, leadership, management

One of the most important questions facing leaders is when they should trust their gut instincts. Our work at McKinsey …

GSK partners with Brazil’s Fiocruz on tropical disease research

November 15, 2010
Research and Development Chagas disease, Fiocruz, GSK, GSK’s Tres Cantos Medicines Development Campus, GlaxoSmithKline, Oswald Cruz Foundation, leishmaniasis

GlaxoSmithKline and the Brazil-based Oswald Cruz Foundation (Fiocruz) are to research and develop new medicines for tropical diseases Chagas and …

Quarter of all cancers found at late stage

November 15, 2010
Cancer, England, NCIN, NHS, National Cancer Intelligence Network, brain cancer, cancer diagnosis, leukaemia

Nearly a quarter of all cancer diagnoses in England came after a patient had been admitted to hospital for emergency …

Irish cost-effectiveness guidelines published

November 15, 2010
Sales and Marketing Dr Mairin Ryan, Economic Evaluation of Health Technologies, HIQA, Health Information and Quality Authority, IPHA, Ireland, Irish Pharmaceutical Healthcare Association, NICE, hta

The Irish government has published new health technology assessment guidelines to help decision-makers estimate the cost-effectiveness of medical treatments. The …

AstraZeneca staff strike as pension talks breakdown

November 15, 2010
Manufacturing and Production AZ, AstraZeneca, AstraZeneca UK Manufacturing, GMB, Hurdsfield Industrial Estate, pensions, strikes, unions

Workers at an AstraZeneca facility in the UK went back on strike for the eighth time last week after talks …

Tylenol recall warrants thorough, public investigation, says ISMP

November 15, 2010
Manufacturing and Production FDA, ISMP, Institute for Safe Medication Practices, Johnson & Jonson, MedWatch, Tylenol, Tylenol recall

Johnson & Jonson’s recall of Tylenol painkiller products was one of the key safety trends identified in the last quarter …

Sam Barnes joins Axon Communications

November 12, 2010
Medical Communications AXON Communications, Joss Lyons-White, Sam Barnes, appointment, medical communications

Surrey, UK-based agency Axon Communications has appointed Sam Barnes director of PR. Sam has over 15 years of experience in healthcare …

Blog footer

Digital Pharma: Pfizer and Boehringer’s online COPD awareness

November 12, 2010
Medical Communications Boehringer Ingelheim, COPD, Digital Pharma blog, Managing COPD, NICE, Pfizer, Spiriva, chronic obstructive pulmonary disease

Pfizer and Boehringer Ingelheim have launched an online campaign to publicise the latest NICE guidelines on COPD to healthcare professionals …

Bavarian Nordic courting cancer vaccine backers

November 12, 2010
Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …

FDA approves Merck’s HIV fat drug Egrifta

November 12, 2010
Research and Development, Sales and Marketing EMD Serono, Egrifta, FDA, HIV, Merck KGaA, abdominal fat in HIV, tesamorelin

US regulatory authorities have approved the first treatment indicated to target abdominal fat in patients with HIV after trials showed …

Germany to cut drug prices by 2 billion euro

November 12, 2010
Sales and Marketing Cornelia Yzer, GKV-Spitzenverband, Germany, IQWIG, Philipp Rosler, VFA, health insurers, healthcare spending, innovative medicines

The lower house of the German Parliament has passed a new law to control the cost of new prescription medicines. …

Avastin packs

NICE stands firm on Avastin rejection

November 12, 2010
Sales and Marketing NICE, Roche, avastin, bevacizumab, colon cancer, metastatic colorectal cancer, patient access scheme

NICE has refused to recommend Roche’s blockbuster cancer drug Avastin for the treatment of metastatic colorectal cancer in its final …

amanda_callaghan

ABPI appoints communications director

November 11, 2010
Research and Development, Sales and Marketing ABPI, Amanda Callaghan, Royal College of Nursing, appointment, research and development, sales and marketing

UK industry body the ABPI has appointed Amanda Callaghan director of corporate communications. She starts the role on 31 January …

systemic lupus erythematosus

UCB lupus candidate shows disease benefits

November 11, 2010
Benlysta, Lupus, UCB, epratuzumab, monoclonal antibody, systemic lupus erythematosus

A new monoclonal antibody targeting the autoimmune disease lupus is continuing to show a positive effect on sufferers, its manufacturer …

Nycomed’s Q3 undermined by pantoprazole decline

November 11, 2010
Sales and Marketing Daxas, Guangdong Techpool Bio-Pharma, Nycomed, Protium, pantoprazole

Nycomed has seen its sales inch downwards in the third quarter, as the decline of its biggest seller pantoprazole continued. …

Pfizer enters drug repositioning collaboration with Biovista

November 11, 2010
Research and Development Biovista, FDA, Neurontin, Pfizer, Pfizer Indications Discovery Unit, drug repositioning, viagra

Pfizer has signed a pilot research agreement with drug repositioning specialist Biovista. The aim of the collaboration is to identify …

Patients in UK cancer trials quadruples

November 11, 2010
Research and Development Cancer Research UK, NCRI, National Cancer Research Institute, UK clinical research, cancer trials

The number of cancer patients in the UK participating in clinical studies has quadrupled in the last decade, according to …

Novartis drops late stage lung cancer candidate

November 11, 2010
Research and Development ASA404, Antisoma, NSCLC, Novartis, cancer research, lung cancer, non small cell lung cancer, non-small cell lung cancer

Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …

The Gateway to Local Adoption Series

Latest content